2018 Exploring New Science in Cardiovascular Medicine

This activity will provide cardiologists with updates in several key areas empowering them to provide improved care to their patients. 

Learning Objectives - At the completion of this program, attendees will be able to:

  1. Define key factors for CV risk and be able to determine when and how to intervene
  2. Discuss the criteria for determining which interventions are optimal for different patient presentations of arrhythmias
  3. Identify appropriate patients for various interventional procedures
  4. Establish a patient-centered approach to antiplatelet and anticoagulant therapies
  5. Discuss the rationale behind the latest guidelines for hypertension and lipid management
  6. Apply case-derived insights to the treatment of patients with cardiomyopathies and heart failure.
  • State of the Art - Advanced Heart Failure/LVAD/Transplant Update

    Contains 4 Component(s), Includes Credits Recorded On: 04/27/2018

    Presented on April 27, 2018 at the 2018 Exploring New Science in Cardiovascular Medicine course. This activity is eligible for 0.75 AOA Category 1-B credits. This CME enduring material is based on the live CME activity of the same title. If you were awarded AOA Category 1-A credit for participation in the live activity, you may not claim credit for participation in the enduring material.

    This activity explores the current epidemiology of heart failure, survival estimate for LVADs, and reviews the currently available LVADs.  Presented at the 2018 Exploring New Science in Cardiovascular Medicine course held April 27-29, 2018 by Jonathan Rich, MD.

    Jonathan Rich, MD

    Associate Professor of Cardiology

    Northwestern University Feinberg School of Medicine
    Chicago, IL

  • Pulmonary Hyptertension: When to Initiate Advanced Therapy

    Contains 4 Component(s), Includes Credits Recorded On: 04/27/2018

    Presented on April 27, 2018 at the 2018 Exploring New Science in Cardiovascular Medicine course. This activity is eligible for 0.75 AOA Category 1-B credits. This CME enduring material is based on the live CME activity of the same title. If you were awarded AOA Category 1-A credit for participation in the live activity, you may not claim credit for participation in the enduring material.

    This activity explores pulmonary hypertension in detail.  The three main pathways targeted by pulmonary hypertension drugs are reviewed.  Presented at the 2018 Exploring New Science in Cardiovascular Medicine course held April 27-29, 2018 by Jonathan Rich, MD.

    Jonathan Rich, MD

    Associate Professor of Cardiology

    Northwestern University Feinberg School of Medicine
    Chicago, IL

  • Hypertension- Are We Going Too Low

    Contains 4 Component(s), Includes Credits Recorded On: 04/27/2018

    Presented on April 27, 2018 at the 2018 Exploring New Science in Cardiovascular Medicine course. This activity is eligible for 0.50 AOA Category 1-B credits. This CME enduring material is based on the live CME activity of the same title. If you were awarded AOA Category 1-A credit for participation in the live activity, you may not claim credit for participation in the enduring material.

    This activity explores the latest AHA/ACC BP guidelines and approach to achieving the guidelines.    The adverse events related to the lower BP goals are also discussed.  Presented at the 2018 Exploring New Science in Cardiovascular Medicine course held April 27-29, 2018 by George Bakris, MD.

    George Bakris, MD

    Professor of Medicine

  • When to Order a Wearable Defibrillator

    Contains 4 Component(s), Includes Credits Recorded On: 04/27/2018

    Presented on April 27, 2018 at the 2018 Exploring New Science in Cardiovascular Medicine course. This activity is eligible for 0.50 AOA Category 1-B credits. This CME enduring material is based on the live CME activity of the same title. If you were awarded AOA Category 1-A credit for participation in the live activity, you may not claim credit for participation in the enduring material.

    This activity explores clinical trials evaluating wearable defibrillators and discusses the power of the devices.  Presented at the 2018 Exploring New Science in Cardiovascular Medicine course held April 27-29, 2018 by Martin C. Burke, DO, FACOI.

    Martin C. Burke, DO, FACOI

    Past President, ACOI Board of Directors

    Past President, ACOI Board of Directors, Founder, Corvita Health & Science, Chicago, IL

  • Cardiac CT: Your Chest Pain Patient CAN be Discharged from the ED

    Contains 4 Component(s), Includes Credits Recorded On: 04/27/2018

    Presented on April 27, 2018 at the 2018 Exploring New Science in Cardiovascular Medicine course. This activity is eligible for 0.50 AOA Category 1-B credits. This CME enduring material is based on the live CME activity of the same title. If you were awarded AOA Category 1-A credit for participation in the live activity, you may not claim credit for participation in the enduring material.

    This activity explores the indication and advantages and disadvantages of cardiac CT.  Presented at the 2018 Exploring New Science in Cardiovascular Medicine course held April 27-29, 2018 by Asif Serajian, DO.

    Asif Serajian, DO

    Program Chair

    Program Chair, Exploring New Science in Cardiovascular Medicine
    Cardiologist 
    Chicago, IL

  • Diabetic Heart Disease- A Ticking Time Bomb

    Contains 4 Component(s), Includes Credits Recorded On: 04/27/2018

    Presented on April 27, 2018 at the 2018 Exploring New Science in Cardiovascular Medicine course. This activity is eligible for 0.25 AOA Category 1-B credits. This CME enduring material is based on the live CME activity of the same title. If you were awarded AOA Category 1-A credit for participation in the live activity, you may not claim credit for participation in the enduring material.

    This activity explores the translational science of diabetes, reviews recent diabetes trials, and examines current treatment guidelines.  Presented at the 2018 Exploring New Science in Cardiovascular Medicine course held April 27-29, 2018 by Robert Chilton, DO, FACOI, FACC.

    Robert J. Chilton, DO, MACOI

    Professor of Medicine

    Professor of Medicine, University of Texas Health Science Center, San Antonio, TX

  • ASCVD Risk Reduction Therapy- Beyond Statins

    Contains 4 Component(s), Includes Credits Recorded On: 04/27/2018

    Presented on April 27, 2018 at the 2018 Exploring New Science in Cardiovascular Medicine course. This activity is eligible for 0.50 AOA Category 1-B credits. This CME enduring material is based on the live CME activity of the same title. If you were awarded AOA Category 1-A credit for participation in the live activity, you may not claim credit for participation in the enduring material.

    This activity explores the interrelationship of insulin resistance to atherosclerosis and examines the current blood pressure and lipid guidelines.  The amplification of CV risk with hypertension and lipids is also reviewed.  Presented on April 27, 2018 at the 2018 Exploring New Science in Cardiovascular Medicine course by Robert Chilton, DO, FACOI, FACC.

    Robert J. Chilton, DO, MACOI

    Professor of Medicine

    Professor of Medicine, University of Texas Health Science Center, San Antonio, TX

  • A Light in the Dark- Cardiac MRI and Risk Mitigation

    Contains 4 Component(s), Includes Credits Recorded On: 04/27/2018

    Presented on April 27, 2018 at the 2018 Exploring New Science in Cardiovascular Medicine course. This activity is eligible for 0.75 AOA Category 1-B credits. This CME enduring material is based on the live CME activity of the same title. If you were awarded AOA Category 1-A credit for participation in the live activity, you may not claim credit for participation in the enduring material.

    This activity explores the use of cardiac imaging to detect myocardial ischemia.  In addition, the most specific and sensitive imaging modalities for assessing myocardial scarring in patients with ischemic cardiomyopathy are reviewed.  Presented at the 2018 Exploring New Science in Cardiovascular Medicine course held April 27-29, 2018 by Ronald Mikolich, MD.

    Ronald Mikolich, MD

    Chief, Section of Cardiology Northeastern Ohio Universities College of Medicine

    Professor of Internal Medicine, Northeastern Ohio Universities College of Medicine
    Director, Advanced Cardiac Imaging, Sharon Regional Health System Diagnostic and Imaging Center
    Poland, OH